The Executive Committee of Gour Medical is made up of Mr. Serge Goldner, Chief Executive Officer, Mr. Christian Bourgeois, Chief Operating Officer, Mrs. Marie-Bénédicte Charpentier, Director of Business Strategies and Development, Mrs. Eva Bleul, Director of Regulatory Affairs and Mr. Jean Steffan, Director of Pharmaceutical Development.
Gour Medical’s Executive Committee’s expertise in animal health ensures:
- Quick and well-informed decisions
- A focused product range prioritizing the needs of mature pets
- Smooth partnering in R&D to develop products that veterinarians will want for their patients
- Strong international brands that will attract commercial partners
Serge Goldner has founded and managed several companies operating internationally in the fields of Life Sciences and new technologies.
He has more than 15 years of experience in entrepreneurship, business development and corporate finance. Prior to founding Gour Medical in 2014, he was Chief Financial Officer of Immune Pharmaceuticals, a Nasdaq-listed biotech company (NASDAQ: IMNP).
Previously, he was a founder and managing partner of Cukierman & Co Life Sciences, an Israeli-European leader in corporate finance.
Christian Bourgeois has many years management experience with several international companies.
Before joining Gour Medical, Christian was, from 2011 to 2016, General Manager France of Ceva Santé Animale. During that time he was also a member of the board and Vice President of the SIMV (Union of the Veterinary Medicine Industry).
Self-taught, between 2001 to 2011, he held a series of management positions in the animal health division of the Pfizer group, notably as Director of the Companion Animals Department, Director of the Ruminants Department and Director of Customer Service.
In recent years he has been involved in three mergers and acquisitions. He was responsible for the integration of the teams in these various transactions by creating a new mindset based on the team and the desire to succeed.
His leadership also allowed him to lead European product launches, while continuing with his duties as managing director.
Marie Bénédicte Charpentier has 30 years’ experience in marketing and strategic planning, including over 13 years in major animal health pharmaceutical groups.
Between 2007 and 2016, she was Director of International Marketing for the Companion Animals Department at Vetoquinol SA, a world leader in animal health. She was responsible for the company’s supply strategy and the launch of several product lines worldwide.
From 2003 to 2007, she was Director of the Companion Animals Business Unit at Novartis Animal Health. Prior to that, she held various marketing and sales positions at multinationals including Nestlé, Danone and Quaker.
Dr. Bleul is a veterinary health regulatory specialist with nearly 20 years of senior leadership experience in the sector.
Prior to joining Gour Medical, she was Director of Regulatory Affairs Europe, Middle East and Africa for Elanco (Basel, Switzerland), a subsidiary of the Eli Lilly Group. Between 2002 and 2014, she held several positions as Manager and then as Head of the Regulatory Affairs Department at Novartis Animal Health (Basel, Switzerland).
Eva holds a Doctorate in Veterinary Medicine from Justus-Liebig University in Giessen, Germany.
With a long career in the development of veterinary medicines, Jean Steffan worked as an international project manager from 1999 to 2013 at Novartis.
He led the development of major veterinary dermatology products such as Atopica® (cyclosporine) and Osurnia® (dog otitis), now marketed globally.
In 2004, he was awarded the “Leading Scientist” award by Novartis, a distinction reserved for high-level scientists who have made an essential contribution to the company.
His expertise lies mainly in clinical development, but his role as project leader has also opened him to dialogue with specialists in the different functions of drug development, including production, formulation, pharmacology, toxicology and regulatory affairs.
Jean has participated in various fields of veterinary medicine through the projects he has collaborated in: breeding control of cattle and sheep, antibiotics, behavioral disorders in pets, parasitology and dermatology.